153 related articles for article (PubMed ID: 23768632)
1. Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen <10 ng/ml.
Li YH; Elshafei A; Li J; Gong M; Susan L; Fareed K; Jones JS
Eur Urol; 2014 Jun; 65(6):1178-83. PubMed ID: 23768632
[TBL] [Abstract][Full Text] [Related]
2. Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: decreased likelihood of finding significant cancer on future biopsy.
Li YH; Elshafei A; Li J; Hatem A; Zippe CD; Fareed K; Jones JS
Urology; 2014 Apr; 83(4):714-8. PubMed ID: 24680442
[TBL] [Abstract][Full Text] [Related]
3. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
[TBL] [Abstract][Full Text] [Related]
4. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
Pepe P; Aragona F
Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
[TBL] [Abstract][Full Text] [Related]
5. When serial prostate biopsy is recommended: most cancers detected are clinically insignificant.
Zaytoun OM; Stephenson AJ; Fareed K; El-Shafei A; Gao T; Levy D; Jones JS
BJU Int; 2012 Oct; 110(7):987-92. PubMed ID: 22416859
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination.
Javali TD; Dwivedi DK; Kumar R; Jagannathan NR; Thulkar S; Dinda AK
Int J Urol; 2014 Mar; 21(3):257-62. PubMed ID: 23980749
[TBL] [Abstract][Full Text] [Related]
7. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
[TBL] [Abstract][Full Text] [Related]
8. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.
Jones JS; Patel A; Schoenfield L; Rabets JC; Zippe CD; Magi-Galluzzi C
J Urol; 2006 Feb; 175(2):485-8. PubMed ID: 16406977
[TBL] [Abstract][Full Text] [Related]
9. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
[TBL] [Abstract][Full Text] [Related]
10. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
12. Type of transrectal ultrasonography probe influences prostate cancer detection rates on repeat prostate biopsy.
Ching CB; Zaytoun O; Moussa AS; Li J; Avallone A; Jones JS
BJU Int; 2012 Jul; 110(2 Pt 2):E46-9. PubMed ID: 22044501
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer detection rate at repeat saturation biopsy: PCPT risk calculator versus PCA3 score versus case-finding protocol.
Pepe P; Aragona F
Can J Urol; 2013 Feb; 20(1):6620-4. PubMed ID: 23433132
[TBL] [Abstract][Full Text] [Related]
14. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
[TBL] [Abstract][Full Text] [Related]
15. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
[TBL] [Abstract][Full Text] [Related]
16. Random biopsy: when, how many and where to take the cores?
Scattoni V; Maccagnano C; Capitanio U; Gallina A; Briganti A; Montorsi F
World J Urol; 2014 Aug; 32(4):859-69. PubMed ID: 24908067
[TBL] [Abstract][Full Text] [Related]
17. Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy.
Oh JJ; Jeong SJ; Lee BK; Jeong CW; Byun SS; Hong SK; Lee SE
BJU Int; 2013 Aug; 112(4):E265-71. PubMed ID: 23432960
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.
Punglia RS; Cullen J; McLeod DG; Chen Y; D'Amico AV
Cancer; 2007 Nov; 110(9):1973-8. PubMed ID: 17886252
[TBL] [Abstract][Full Text] [Related]
19. Increasing prostate-specific antigen levels differently influence prostate cancer detection rates of two different 12-core prostate biopsy schemes.
Lodeta B; Benko G; Trkulja V
Urol Int; 2013; 91(1):75-80. PubMed ID: 23614932
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
Stewart CS; Leibovich BC; Weaver AL; Lieber MM
J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]